Isolates | RXN | Antimicrobial agents (%) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CN | VA | AK | E | C | SXT | NOR | P | KF | CRO | TE | CIP | AP | DO | ||
S.aures (n = 47) | S | 45 (96) | 47 (100) | 47 (100) | 40 (85.1) | 40 (85.1) | 44 (94) | 45 (96) | 4 (8.5) | 33 (70.2) | 40 (85.1) | 23 (49) | 45 (96) | 2 (4.3) | 34 (72.4) |
R | 2 (4) | - | - | 7 (14.9) | 7 (14.9) | 3 (6) | 2 (4) | 43 (91.5) | 14 (29.8) | 7 (14.9) | 24 (51) | 2 (4) | 45 (95.7) | 13 (27.6) | |
CONS (n = 21) | S | 17 (81) | 21 (100) | 21 (100) | 13 (62) | 14 (67) | 18 (86) | 16 (76.2) | 5 (24) | 6 (29) | 15 (71.4) | 10 (48) | 16 (76.2) | 2 (9.5) | 15 (71.4) |
R | 4 (19) | - | - | 8 (38) | 7 (33) | 3 (14) | 5 (23.8) | 16 (76) | 15 (71) | 6 (28.6) | 11 (52) | 5 (23.8) | 19 (90.5) | 6 (28.6) | |
Total (n = 68) | S | 62 (91.2) | 68 (100) | 68 (100) | 53 (78) | 54 (79.4) | 62 (91.2) | 61 (90) | 9 (13.2) | 39 (57.4) | 55 (81) | 33 (48.5) | 61 (90) | 4 (6) | 49 (72.1) |
R | 6 (8.8) | - | - | 15 (22) | 14 (20.6) | 6 (8.8) | 7 (10) | 59 (86.8) | 29 (42.6) | 13 (19) | 35 (51.5) | 7 (10) | 64 (94) | 19 (27.9) |